These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 14978071)

  • 1. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma.
    Redecke V; Häcker H; Datta SK; Fermin A; Pitha PM; Broide DH; Raz E
    J Immunol; 2004 Mar; 172(5):2739-43. PubMed ID: 14978071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities.
    Chisholm D; Libet L; Hayashi T; Horner AA
    J Allergy Clin Immunol; 2004 Mar; 113(3):448-54. PubMed ID: 15007346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.
    Dillon S; Agrawal A; Van Dyke T; Landreth G; McCauley L; Koh A; Maliszewski C; Akira S; Pulendran B
    J Immunol; 2004 Apr; 172(8):4733-43. PubMed ID: 15067049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses.
    Revets H; Pynaert G; Grooten J; De Baetselier P
    J Immunol; 2005 Jan; 174(2):1097-103. PubMed ID: 15634935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity.
    Rodríguez D; Keller AC; Faquim-Mauro EL; de Macedo MS; Cunha FQ; Lefort J; Vargaftig BB; Russo M
    J Immunol; 2003 Jul; 171(2):1001-8. PubMed ID: 12847273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.
    Netea MG; Ferwerda G; de Jong DJ; Jansen T; Jacobs L; Kramer M; Naber TH; Drenth JP; Girardin SE; Kullberg BJ; Adema GJ; Van der Meer JW
    J Immunol; 2005 May; 174(10):6518-23. PubMed ID: 15879155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells.
    Dabbagh K; Dahl ME; Stepick-Biek P; Lewis DB
    J Immunol; 2002 May; 168(9):4524-30. PubMed ID: 11970998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88.
    Eisenbarth SC; Zhadkevich A; Ranney P; Herrick CA; Bottomly K
    J Immunol; 2004 Apr; 172(7):4527-34. PubMed ID: 15034070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase.
    Hayashi T; Beck L; Rossetto C; Gong X; Takikawa O; Takabayashi K; Broide DH; Carson DA; Raz E
    J Clin Invest; 2004 Jul; 114(2):270-9. PubMed ID: 15254594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.
    Sun J; Walsh M; Villarino AV; Cervi L; Hunter CA; Choi Y; Pearce EJ
    J Immunol; 2005 Jan; 174(2):742-51. PubMed ID: 15634894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
    Gelman AE; Zhang J; Choi Y; Turka LA
    J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
    Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
    J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.
    Equils O; Schito ML; Karahashi H; Madak Z; Yarali A; Michelsen KS; Sher A; Arditi M
    J Immunol; 2003 May; 170(10):5159-64. PubMed ID: 12734363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7RP-1 is not required for the generation of Th2 responses in a model of allergic airway inflammation but is essential for the induction of inhalation tolerance.
    Gajewska BU; Tafuri A; Swirski FK; Walker T; Johnson JR; Shea T; Shahinian A; Goncharova S; Mak TW; Stämpfli MR; Jordana M
    J Immunol; 2005 Mar; 174(5):3000-5. PubMed ID: 15728513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.
    Takeuchi O; Sato S; Horiuchi T; Hoshino K; Takeda K; Dong Z; Modlin RL; Akira S
    J Immunol; 2002 Jul; 169(1):10-4. PubMed ID: 12077222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma.
    Serebrisky D; Teper AA; Huang CK; Lee SY; Zhang TF; Schofield BH; Kattan M; Sampson HA; Li XM
    J Immunol; 2000 Nov; 165(10):5906-12. PubMed ID: 11067952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner.
    Sano K; Shirota H; Terui T; Hattori T; Tamura G
    J Immunol; 2003 Mar; 170(5):2367-73. PubMed ID: 12594259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
    Hessel EM; Chu M; Lizcano JO; Chang B; Herman N; Kell SA; Wills-Karp M; Coffman RL
    J Exp Med; 2005 Dec; 202(11):1563-73. PubMed ID: 16314434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
    Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
    J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response.
    Didierlaurent A; Ferrero I; Otten LA; Dubois B; Reinhardt M; Carlsen H; Blomhoff R; Akira S; Kraehenbuhl JP; Sirard JC
    J Immunol; 2004 Jun; 172(11):6922-30. PubMed ID: 15153511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.